A review on the added value of whole-body MRI in metastatic lobular breast cancer

Autor: Basrull N, Bhaludin, Nina, Tunariu, Dow-Mu, Koh, Christina, Messiou, Alicia F, Okines, Sophie E, McGrath, Alistair E, Ring, Marina M, Parton, Bhupinder, Sharma, Tanja, Gagliardi, Steven D, Allen, Romney, Pope, Stephen R D, Johnston, Kate, Downey

Publikováno v: European radiology. 32(9)

Invasive lobular breast carcinomas (ILC) account for approximately 15% of breast cancer diagnoses. They can be difficult to diagnose both clinically and radiologically, due to their infiltrative growth pattern. The pattern of metastasis of ILC is unu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1dcd6f7c5b1075a1dd806c6f3dd935fe
https://pubmed.ncbi.nlm.nih.gov/35384456

The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study.

Autor: Corianò M; Department of Medicine and Surgery, Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy.; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Tommasi C; Department of Medicine and Surgery, Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy., Dinh ATL; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK.; Vietnam National Cancer Hospital, Hanoi, Vietnam., Needham J; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Aziz H; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Joharatnam-Hogan N; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Cunningham N; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Waterhouse J; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Sun M; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK.; University College London Medical School, London, UK., Turkes F; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Pellegrino B; Department of Medicine and Surgery, Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy., McGrath S; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Okines A; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Parton M; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Turner N; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Johnston S; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Musolino A; Department of Medicine and Surgery, Medical Oncology and Breast Unit, University Hospital of Parma, Parma, Italy., Ring A; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK., Battisti NML; Breast Unit - Department of Medicine, The Royal Marsden NHS Foundation Trust, London, UK. Nicolo.Battisti@rmh.nhs.uk.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Aug; Vol. 206 (3), pp. 603-614. Date of Electronic Publication: 2024 May 14.

Vinorelbine After Prior Treatment With Eribulin for Advanced Breast Cancer: A Single-Centre Experience Suggesting Cross-Resistance.

Autor: Okines AFC; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Alicia.Okines@rmh.nhs.uk., Irfan T; The Royal Marsden NHS Foundation Trust, London, UK., Mohammed K; The Royal Marsden NHS Foundation Trust, London, UK., Ring A; The Royal Marsden NHS Foundation Trust, London, UK., Parton M; The Royal Marsden NHS Foundation Trust, London, UK., Kipps E; The Royal Marsden NHS Foundation Trust, London, UK., Johnston S; The Royal Marsden NHS Foundation Trust, London, UK., Turner NC; The Royal Marsden NHS Foundation Trust, London, UK.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2022 Oct; Vol. 22 (7), pp. e825-e831. Date of Electronic Publication: 2022 May 27.

Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.

Autor: Okines A; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK. Alicia.Okines@rmh.nhs.uk., Irfan T; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Asare B; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Mohammed K; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Osin P; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Nerurkar A; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Smith IE; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Parton M; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Ring A; The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, SM2 5PT, UK., Johnston S; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK., Turner NC; The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2022 Apr; Vol. 192 (3), pp. 563-571. Date of Electronic Publication: 2022 Feb 04.

Impact of timing of adjuvant chemothapy for early breast cancer: the Royal Marsden Hospital experience.

Autor: Okines AFC; The Royal Marsden NHS Foundation Trust, London and Surrey, UK. Alicia.Okines@rmh.nhs.uk., Kipps E; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Irfan T; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Coakley M; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Angelis V; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Asare B; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Mohammed K; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Walsh G; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Ring A; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Johnston SRD; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Parton M; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Turner NC; The Royal Marsden NHS Foundation Trust, London and Surrey, UK., Smith IE; The Royal Marsden NHS Foundation Trust, London and Surrey, UK.

Publikováno v: British journal of cancer [Br J Cancer] 2021 Jul; Vol. 125 (2), pp. 299-304. Date of Electronic Publication: 2021 May 20.